Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    St. Martin's Publishing Group
    UID:
    kobvindex_ZLB34872282
    ISBN: 9781250280374
    Content: " Winners of the Paul Ehrlich PrizeThe dramatic story of the married scientists who founded BioNTech and developed the first vaccine against COVID-19. Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. His confidence was built upon almost thirty years of research. While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA,they believed it could be harnessed to redirect the immune system's forces against any number of diseases. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first,but by the time Sars-Cov-2 was discovered in Wuhan, China, BioNTech was prepared to deploy cutting edge technology and create the world's first clinically approved inoculation for the coronavirus. The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age,it will reveal how Doctors Sahin and Türeci were able to develop twenty vaccine candidates within weeks, convince Big Pharma to support their ambitious project, navigate political interference from the Trump administration and the European Union, and provide more than three billion doses of the Pfizer/BioNTech vaccine to countries around the world in record time. Written by Joe Miller8212 the Financial Times' Frankfurt correspondent who covered BioNTech's COVID-19 project in real time8212 with contributions from Sahin and Türeci, as well as interviews with more than sixty scientists, politicians, public health officials, and BioNTech staff, the book covers key events throughout the extraordinary year, as well as exploring the scientific, economic, and personal background of each medical innovation. Crafted to be both completely accessible to the average reader and filled with details that will fascinate seasoned microbiologists, The Vaccine explains the science behind the breakthrough, at a time when public confidence in vaccine safety and efficacy is crucial to bringing an end to this pandemic. "
    Content: Biographisches: " Joe Miller is the Frankfurt correspondent for Financial Times . He previously reported for BBC News in London, New York, Delhi, and Berlin." Rezension(2): "Angela Merkel, former Chancellor of Germany, Süddeutsche Zeitung : I have now read the book by Joe Miller about the development of the vaccine at BioNTech. Ugur Sahin had already understood the scale of the pandemic on 24 January. I wasn't that quick." Rezension(3): " The Times (London):Özlem Türeci and Ugur Sahin are rapidly becoming the most celebrated marriage in science since Marie and Pierre Curie discovered radioactivity." Rezension(4): " Financial Times (FT People of the Year):They are the symbol of a remarkable scientific and business success story." Rezension(5): " Bloomberg :The story of their quest to use a novel scientific method to defeat that disease, as well as cancer and others, would suffice to make them heroes of our time." Rezension(6): "〈a href=http://www.publishersweekly.com target=blank〉〈img src=https://images.contentreserve.com/pw_logo.png alt=Publisher's Weekly border=0 /〉〈/a〉: January 10, 2022 Financial Times correspondent Miller delivers a fascinating survey of the remarkable achievements of doctors T252" Rezension(7): "〈a href=http://www.kirkusreviews.com target=blank〉〈img src=https://images.contentreserve.com/kirkus_logo.png alt=Kirkus border=0 /〉〈/a〉: January 15, 2022 The story of the development of the first effective Covid-19 vaccine. Readers of Gregory Zuckerman's excellent A Shot To Save the World learned about the complex mix of unparalleled science, rampant ambition, and fierce competition that led to the creation of a viable vaccine. Miller, the Frankfurt correspondent for the Financial Times who reported on the scientific race, tells a different but equally gripping story that emphasizes aggressive German startup BioNTech, founded by the brilliant husband-and-wife team of T�reci and 350"
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages